| Product Code: ETC7544234 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Gastroparesis Drug Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Gastroparesis Drug Market Revenues & Volume, 2021 & 2031F |
3.3 India Gastroparesis Drug Market - Industry Life Cycle |
3.4 India Gastroparesis Drug Market - Porter's Five Forces |
3.5 India Gastroparesis Drug Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Gastroparesis Drug Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 India Gastroparesis Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Gastroparesis Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastroparesis in India |
4.2.2 Growing awareness about gastroparesis and available treatment options |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in India |
4.3 Market Restraints |
4.3.1 High cost associated with gastroparesis drugs |
4.3.2 Limited availability of specialized healthcare professionals for gastroparesis treatment in India |
4.3.3 Stringent regulatory requirements for drug approval in the Indian market |
5 India Gastroparesis Drug Market Trends |
6 India Gastroparesis Drug Market, By Types |
6.1 India Gastroparesis Drug Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Gastroparesis Drug Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Gastroparesis Drug Market Revenues & Volume, By Antiemetic Agents, 2021- 2031F |
6.1.4 India Gastroparesis Drug Market Revenues & Volume, By Prokinetic Agents, 2021- 2031F |
6.1.5 India Gastroparesis Drug Market Revenues & Volume, By Botulinum Toxin Injections, 2021- 2031F |
6.2 India Gastroparesis Drug Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 India Gastroparesis Drug Market Revenues & Volume, By Diabetic Gastroparesis, 2021- 2031F |
6.2.3 India Gastroparesis Drug Market Revenues & Volume, By Post-Surgical Gastroparesis, 2021- 2031F |
6.2.4 India Gastroparesis Drug Market Revenues & Volume, By Idiopathic Gastroparesis, 2021- 2031F |
6.2.5 India Gastroparesis Drug Market Revenues & Volume, By Other Disease Types, 2021- 2031F |
6.3 India Gastroparesis Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Gastroparesis Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 India Gastroparesis Drug Market Revenues & Volume, By Clinic, 2021- 2031F |
6.3.4 India Gastroparesis Drug Market Revenues & Volume, By Pharmacies, 2021- 2031F |
7 India Gastroparesis Drug Market Import-Export Trade Statistics |
7.1 India Gastroparesis Drug Market Export to Major Countries |
7.2 India Gastroparesis Drug Market Imports from Major Countries |
8 India Gastroparesis Drug Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for gastroparesis drugs |
8.2 Number of healthcare facilities offering gastroparesis treatment |
8.3 Adoption rate of new gastroparesis drug therapies in India |
9 India Gastroparesis Drug Market - Opportunity Assessment |
9.1 India Gastroparesis Drug Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Gastroparesis Drug Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 India Gastroparesis Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Gastroparesis Drug Market - Competitive Landscape |
10.1 India Gastroparesis Drug Market Revenue Share, By Companies, 2024 |
10.2 India Gastroparesis Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here